NEA Management Company, LLC Q2 2021 Filing
Filed August 2, 2021
Portfolio Value
$7.7T
Holdings
63
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (63 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —BRIGHT HEALTH GROUP INC | 218,212,128 | $3.7T | 48.77% | |
| 2 | COURCOURSERA INC | 16,603,063 | $656.8B | 8.56% | |
| 3 | NETCLOUDFLARE INC | 2,763,583 | $292.5B | 3.81% | |
| 4 | CRSPCRISPR THERAPEUTICS AG | 1,590,002 | $257.4B | 3.35% | |
| 5 | —DESKTOP METAL INC | 19,410,631 | $223.2B | 2.91% | |
| 6 | ALLKGUSDALLAKOS INC | 2,164,704 | $184.8B | 2.41% | |
| 7 | —EARGO INC | 4,520,670 | $180.4B | 2.35% | |
| 8 | GLUEMONTE ROSA THERAPEUTICS INC | 7,703,205 | $174.9B | 2.28% | |
| 9 | ARDXARDELYX INC | 13,633,582 | $103.3B | 1.35% | |
| 10 | BILLBILL COM HLDGS INC | 560,774 | $102.7B | 1.34% | |
| 11 | OYSTOYSTER PT PHARMA INC | 5,925,287 | $101.9B | 1.33% | |
| 12 | RYTMRHYTHM PHARMACEUTICALS INC | 4,912,306 | $96.2B | 1.25% | |
| 13 | NKTXNKARTA INC | 2,904,974 | $92.1B | 1.20% | |
| 14 | —METROMILE INC | 9,384,295 | $85.9B | 1.12% | |
| 15 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 17,082,611 | $72.8B | 0.95% | |
| 16 | MIRMMIRUM PHARMACEUTICALS INC | 4,187,801 | $72.4B | 0.94% | |
| 17 | AUPHAURINIA PHARMACEUTICALS INC | 5,172,683 | $67.0B | 0.87% | |
| 18 | CVRXCVRX INC | 2,370,858 | $66.4B | 0.86% | |
| 19 | OPENOPENDOOR TECHNOLOGIES INC | 3,333,276 | $59.1B | 0.77% | |
| 20 | ANNXANNEXON INC | 2,497,661 | $56.2B | 0.73% | |
| 21 | TREURTRILLIUM THERAPEUTICS INC | 5,736,363 | $55.6B | 0.72% | |
| 22 | —AKOUOS INC | 4,298,488 | $53.9B | 0.70% | |
| 23 | VTGNUSDVISTAGEN THERAPEUTICS INC | 16,302,596 | $51.4B | 0.67% | |
| 24 | —CASPER SLEEP INC | 6,226,130 | $51.3B | 0.67% | |
| 25 | OKURRENEO PHARMACEUTICALS INC | 4,786,921 | $44.7B | 0.58% | |
| 26 | GRTXGALERA THERAPEUTICS INC | 4,362,986 | $42.9B | 0.56% | |
| 27 | BDTXBLACK DIAMOND THERAPEUTICS INC | 3,449,845 | $42.1B | 0.55% | |
| 28 | INZYINOZYME PHARMA INC | 2,444,379 | $41.7B | 0.54% | |
| 29 | YB4PSAVARA INC | 24,137,931 | $41.0B | 0.53% | |
| 30 | —AFFIMED NV | 4,426,488 | $37.6B | 0.49% | |
| 31 | UPSTUPSTART HLDGS INC | 287,092 | $35.9B | 0.47% | |
| 32 | BEBLOOM ENERGY CORP | 1,333,333 | $35.8B | 0.47% | |
| 33 | VRNAVERONA PHARMA PLC | 5,108,563 | $33.4B | 0.44% | |
| 34 | —IMARA INC | 4,017,170 | $31.7B | 0.41% | |
| 35 | TPIVDEURMARKER THERAPEUTICS INC | 10,714,285 | $29.9B | 0.39% | |
| 36 | 0HJQAVEO PHARMACEUTICALS INC | 3,952,958 | $26.1B | 0.34% | |
| 37 | —PHASEBIO PHARMACEUTICALS INC | 6,643,704 | $24.7B | 0.32% | |
| 38 | MEIPUSDMEI PHARMA INC | 8,533,072 | $24.3B | 0.32% | |
| 39 | GNCAQGENOCEA BIOSCIENCES INC | 10,376,936 | $24.3B | 0.32% | |
| 40 | —SATSUMA PHARMACEUTICALS INC | 3,142,958 | $22.2B | 0.29% | |
| 41 | GLYCEURGLYCOMIMETICS INC | 9,089,041 | $21.1B | 0.27% | |
| 42 | GONGERON CORP | 13,461,538 | $19.0B | 0.25% | |
| 43 | XENEXENON PHARMACEUTICALS INC | 992,107 | $18.5B | 0.24% | |
| 44 | CTIC1USDCTI BIOPHARMA CORP | 7,140,450 | $17.9B | 0.23% | |
| 45 | CSBRCHAMPIONS ONCOLOGY INC | 1,713,720 | $17.6B | 0.23% | |
| 46 | ADXNUSDADDEX THERAPEUTICS LTD | 180,000 | $17.2B | 0.22% | |
| 47 | —SYNLOGIC INC | 4,229,410 | $16.5B | 0.21% | |
| 48 | IVAINVENTIVA SA | 1,041,666 | $14.2B | 0.19% | |
| 49 | —OBSEVA SA | 4,586,563 | $13.9B | 0.18% | |
| 50 | TRVITREVI THERAPEUTICS INC | 5,940,796 | $13.4B | 0.17% | |
| 51 | —STRONGBRIDGE BIOPHARMA PLC | 4,141,308 | $12.3B | 0.16% | |
| 52 | —METACRINE INC | 3,062,977 | $11.6B | 0.15% | |
| 53 | LXRXLEXICON PHARMACEUTICALS INC | 2,382,286 | $10.9B | 0.14% | |
| 54 | LQDALIQUIDIA TECHNOLOGIES INC | 2,486,062 | $7.1B | 0.09% | |
| 55 | —TREVENA INC | 3,811,691 | $6.4B | 0.08% | |
| 56 | 4NX1LUMOS PHARMA INC | 526,663 | $5.3B | 0.07% | |
| 57 | —REGULUS THERAPEUTICS INC | 6,451,056 | $5.2B | 0.07% | |
| 58 | ERYP1EURERYTECH PHARMA SA | 625,000 | $3.0B | 0.04% | |
| 59 | TCONTRACON PHARMACEUTICALS INC | 346,718 | $2.3B | 0.03% | |
| 60 | OVASUSDTEMPEST THERAPEUTICS INC | 117,785 | $1.3B | 0.02% | |
| 61 | —VECTIVBIO HLDG AG | 67,069 | $782.0M | 0.01% | |
| 62 | —AKARI THERAPEUTICS PLC | 452,167 | $782.0M | 0.01% | |
| 63 | RYIVIRACTA THERAPEUTICS INC | 37,093 | $421.0M | 0.01% |